Clinical Trial

A Study to Compare to PK Characteristics and Safety Profiles Between PA-111 and PA-111A

Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated April 17, 2025 (before its estimated May 2025 completion). Its status may not reflect the trial's current state.
Summary
Primary endpoint of this study is to evaluate the pharmacokinetic characteristics of PA-111 in healthy subjects.
Trial Details
NCT Number NCT06932705
Lead Sponsor Addpharma Inc.
Conditions Mixed Dyslipidemia
Enrollment 48 participants
Start Date 2025-04
Primary Completion 2025-05 (estimated)
Study Completion 2025-05 (estimated)
Updated on ClinicalTrials.gov 2025-04-17